Anders, Carey K <br/><br/>
Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer.  [electronic resource] 

 -  Cancer investigation  Jan 2009 
 - 13-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-4192 
<br/><br/><label>Standard No.: </label>10.1080/07357900802484944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--economics<br/>Breast Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Female<br/>Humans<br/>Models, Economic<br/>Time Factors